( provokes the body into producing histam...)Allergic Individuals Should Keep Away from Cats, Say UK Scientists,Health
Navigation Links
Allergic Individuals Should Keep Away from Cats, Say UK Scientists
provokes the body into producing histamine, a protein.
The histamine produces swelling and irritation of the upper airways and causes typical hay fever and asthmatic symptoms.
People who have had asthmatic bronchitis as children in a household with pets, especially a cat, are at a high risk of developing allergies towards cats as they get older.
Cat allergen is present on very small particles that readily become airborne when disturbed and are easily inhaled.
When a person experiences an allergic response, a chemical called human immunoglobulin, or IgE, produced by the immune system in response to the presence of allergens such as cat hair, binds to specific receptors on the surface of immune cells. This triggers the release of histamine in the body, causing symptoms such as itching, sneezing and runny eyes and nose.
'"/>
Related medicine news :
1. Diet Can Influence Allergic Skin Reactions
2. New Treatment For People Allergic To Cats
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children
6. Allergic reaction to DTaP vaccine persists in children
7. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
8. Eye Drug Macugen Shows Allergic Reactions
9. Allergic to Kisses?
10. Preventive Measures Proved Ineffective in Allergic Children
11. New Cooperative Research Center for Allergic Disease
Post Your Comments:
(Date:12/1/2009)...ESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ -...001 and have expanded over the years serving the t...ility which was originally set up in an area of 20...ces, as part of the suite of services by Max Neema... a valuable offering. ,, The pharmacy inventory...
(Date:12/1/2009)...HINGTON, Dec. 1 Individ...ore likely than those with traditional coverage to...be more engaged in wellness programs, and to be mo...ter in holding down costs, according to survey res...nefit Research Institute (EBRI). ,, At the sam...
(Date:12/1/2009)...RT LAUDERDALE, Fla., Dec. 1 OrbusN...ollment in the randomized clinical trial of the Co...Stent). ,, A prospective, randomized, multicent...f an ablu M inal sirolimus coat ED bio- E n... to 20 sites in Asia, Australia, Europe and South ...
(Date:12/1/2009)...ents in California are unable to successfully obta...ospitals despite recent state legislation intended... study. , Posing as low-income uninsured patient...than one-third of the hospitals they approached an...an those allowed under California law, according t...
(Date:12/1/2009)... Lumension announces general availability... to deliver end-to-end endpoint management capabil...management console architecture. , ...-- Lumension, a global leader in endpoint manageme...® Endpoint Management and Security Suite (LEMS...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6[0] Max Neeman International Expands Its Pharmacy Services Facility In Delhi[0] New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs[0] OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent[0] Hospital price transparancy laws in California fall short, study finds[0] New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities
...pril 22 Halo Pharmaceutical, this week announced ...rom The Provident Bank to expand its operations. ,... held full-service, specialty pharmaceutical compa...ed industries. , , "Provident is a respected loc...
...nd mother teams up with the March of Dimes and san...ation campaign , , WHITE PLAINS, N.Y. and SWIFTWA...to hear their baby,s first babbles and coos, there... commonly known as whooping cough. Ms. Lopez has j...
...22 ResMed Inc. (NYSE: RMD ), announced today th...esults for the third quarter and nine months of fi...lease with ResMed,s results will be issued after 1...rence call is scheduled to begin at 1:30 p.m. Paci...
...s larger trials needed to assess therapy over long... News) -- Acupuncture reduces severe dry mouth (xe...ead and neck cancer, a small pilot study suggests....e dental oncology department at the University of ...
...esearch, study finds older people taking NSAIDs mo... April 22 (HealthDay News) -- Research has suggest... disease might want to take daily doses of painkil...ent dementia?, the answer based on our study woul...
...itish Columbia researchers have discovered a "mole... blood stem cell transplants, a procedure currentl...,s lymphoma and aplastic anemia. , During a blood... new blood. The stem cells then need to travel to ...
Other Medicine News:Health News:Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident Bank 2Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 2Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 3Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 4Health News:Video: Jennifer Lopez Joins the Fight Against Pertussis in New PSAs 5Health News:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results 2Health News:Acupuncture Cuts Dry Mouth in Cancer Patients 2Health News:Painkillers May Not Protect Against Dementia 2Health News:Painkillers May Not Protect Against Dementia 3Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident BankVideo: Jennifer Lopez Joins the Fight Against Pertussis in New PSAsResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 ResultsAcupuncture Cuts Dry Mouth in Cancer PatientsPainkillers May Not Protect Against DementiaUBC research finds molecular "key" to successful blood stem cell transplants
(Date:12/1/2009)... Dec. 1 CCS Medical, Inc. a leadin... today announced that it has received approval fro...of Delaware (the "Court") for its bidding procedur...ale of substantially all of its assets. ,, Purs...t approved bidding procedures for the sale of subs...
(Date:12/1/2009)... 1 CEL-SCI Corporation (...nd a developer of vaccines and therapeutics for th... announced today that it has retained the services...n (CRO) to run CEL-SCI,s upcoming Phase III clinic...with the Company,s lead product candidate, Multiki...
(Date:12/1/2009)... Dec. 1 MedQuist Inc. ...-enabled clinical documentation services, today an...dial Design, Inc. has been integrated with SpeechQ...cognition system. The solution is being demonstrat...SNA) convention November 29 through December 2. ...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 1Insmed Announces Addition to the Russell 3000 28R 29 Index 12842 2EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 1EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 2EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 3EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 12841 4YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 1YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 2YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 3YoCream Announces the First Soft Serve Frozen Yogurt With Beneficial Probiotics Clinically Proven to Strengthen the Digestive System 50368 4[0] CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures[0] CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine[0] MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology
...-Company to Host Conference Call at 9:00 a.m. EDT-... Corp. (Nasdaq: MEMY ) today announced top-line d...d, placebo-controlled Phase 2a study,of MEM 1003, ...zheimer,s,disease. The trial enrolled 183 subjects... 40 centers in the United States and included mono...
...ORLANDO, Fla., Oct. 13 Acutely ill, hospitalized,...rovement in symptoms,after taking INVEGA(TM) (pali...SEROQUEL(R)(a) (quetiapine) and placebo. Symptom i...ve days into therapy and continued,through the end...inary data,presented today at the 20th Annual U.S....
Other Medicine Technology:Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 2Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 3Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 2INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 3INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 5INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 6INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 7| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |